Gregory N. Fuller

41.9k total citations · 6 hit papers
416 papers, 20.2k citations indexed

About

Gregory N. Fuller is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Gregory N. Fuller has authored 416 papers receiving a total of 20.2k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Genetics, 138 papers in Molecular Biology and 84 papers in Oncology. Recurrent topics in Gregory N. Fuller's work include Glioma Diagnosis and Treatment (157 papers), Meningioma and schwannoma management (44 papers) and Neuroblastoma Research and Treatments (29 papers). Gregory N. Fuller is often cited by papers focused on Glioma Diagnosis and Treatment (157 papers), Meningioma and schwannoma management (44 papers) and Neuroblastoma Research and Treatments (29 papers). Gregory N. Fuller collaborates with scholars based in United States, China and Canada. Gregory N. Fuller's co-authors include Raymond Sawaya, Eric C. Holland, Chengkai Dai, Joseph Celestino, Amy B. Heimberger, Frederick F. Lang, Norman E. Leeds, John de Groot, Laura Schaefer and Ian E. McCutcheon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Gregory N. Fuller

399 papers receiving 19.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

2000 705 citations Raymond Sawaya, Gregory N. Fuller et al. profile →
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

2001 546 citations Gregory N. Fuller et al. profile →
Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after Treatment

2000 507 citations Ashok J. Kumar, Gregory N. Fuller et al. profile →
PD-L1 expression and prognostic impact in glioblastoma

2015 457 citations Jun Wei, Ling-Yuan Kong et al. profile →
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

2020 310 citations Kenneth Aldape, Gregory N. Fuller et al. profile →
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

2018 287 citations Jun Wei, Anantha Marisetty et al. profile →

Peers

Countries citing papers authored by Gregory N. Fuller

Since Specialization

Citations

This map shows the geographic impact of Gregory N. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory N. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory N. Fuller more than expected).

Fields of papers citing papers by Gregory N. Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory N. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory N. Fuller. The network helps show where Gregory N. Fuller may publish in the future.

Co-authorship network of co-authors of Gregory N. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory N. Fuller. A scholar is included among the top collaborators of Gregory N. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory N. Fuller. Gregory N. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adoption of the T2-FLAIR Mismatch Sign among Radiologists: How Well Are We Doing? 2025 ·American Journal of Neuroradiology ·(unknown), (unknown), Burak Berksu Ozkara, Ziyi Li, (unknown), (unknown), Max Wintermark, Gregory N. Fuller	0
2	Subependymomas of the fourth ventricle: To operate or not to operate? 2023 ·Journal of Clinical Neuroscience ·Ali S. Haider, Ian E. McCutcheon, Chibawanye Ene, Gregory N. Fuller, Donald F. Schomer, Maria Gule-Monroe, Franco DeMonte, Sherise D. Ferguson, Frederick F. Lang, Sujit S. Prabhu, Shaan M. Raza, Dima Suki, Jeffrey S. Weinberg, Raymond Sawaya	0
3	CXCR4 expression is associated with proneural‐to‐mesenchymal transition in glioblastoma 2022 ·International Journal of Cancer ·Abdul Wali Khan, Sungho Lee, Akdes Serin Harmancı, Rajan Patel, Khatri Latha, Yuhui Yang, Anantha Marisetty, Hyun Kyoung Lee, Amy B. Heimberger, Gregory N. Fuller, Benjamin Deneen, (unknown)	23
4	Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance 2021 ·Cells ·Travis C. Salzillo, (unknown), Joseph Weygand, (unknown), Joy Gumin, Niki M. Zacharias, Seth T. Gammon, David Piwnica‐Worms, Gregory N. Fuller, Christopher J. Logothetis, Frederick F. Lang, Pratip K. Bhattacharya	9
5	Anti–PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells 2020 ·Clinical Cancer Research ·Ganesh Rao, Khatri Latha, Martina Ott, Aria Sabbagh, Anantha Marisetty, Xiaoyang Ling, Daniel Zamler, Tiffany Doucette, Yuhui Yang, Ling‐Yuan Kong, Jun Wei, Gregory N. Fuller, Fernando Benavides, Adam M. Sonabend, James P. Long, Shulin Li, Michael A. Curran, Amy B. Heimberger	80
6	Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy 2020 ·Clinical Cancer Research ·Martina Ott, Cynthia Kassab, Anantha Marisetty, Yuuri Hashimoto, Jun Wei, Daniel Zamler, Jia-Shiun Leu, Karl-Heinz Tomaszowski, Aria Sabbagh, Dexing Fang, Pravesh Gupta, Waldemar Priebe, Rafał Zieliński, Jared K. Burks, James P. Long, Ling-Yuan Kong, Gregory N. Fuller, John DeGroot, Erik P. Sulman, Amy B. Heimberger	41
7	Imaging-Based Algorithm for the Local Grading of Glioma 2020 ·American Journal of Neuroradiology ·(unknown), (unknown), Jeffrey S. Weinberg, Sujit S. Prabhu, Jackson Hamilton, John D. Hazle, Gregory N. Fuller, Veerabhadran Baladandayuthapani, David Fuentes, Dawid Schellingerhout	11
8	Prospective Clinical Sequencing of Adult Glioma 2019 ·Molecular Cancer Therapeutics ·Siyuan Zheng, Kristin Alfaro-Munoz, Wei Wei, Xiaojing Wang, Fang Wang, Agda Karina Eterovic, Kenna Shaw, Funda Meric‐Bernstam, Gregory N. Fuller, Ken Chen, Roel G.W. Verhaak, Gordon B. Mills, W. K. Alfred Yung, Shiao-Pei Weathers, John de Groot	15
9	Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis 2019 ·Cancer Research ·Yaohui Chen, Runping Fang, Yue Chen, Guoqiang Chang, Peng Li, Qing Guo, Jing Wang, Aidong Zhou, Sicong Zhang, Gregory N. Fuller, Xiaobing Shi, Suyun Huang	47
10	RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report 2019 ·Cancer Genetics ·Nazanin Majd, (unknown), (unknown), (unknown), Gregory N. Fuller, Jason T. Huse, Caroline Chung, Leena Ketonen, Mark D. Anderson, Marta Peñas-Prado	4
11	A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models 2018 ·Clinical Cancer Research ·Pascal O. Zinn, Sanjay K. Singh, Aikaterini Kotrotsou, Islam Hassan, Ginu Thomas, Markus M. Luedi, Ahmed Elakkad, Nabil Elshafeey, (unknown), (unknown), Joy Gumin, Gregory N. Fuller, John de Groot, Veera Baladandayuthapani, Erik P. Sulman, Ashok J. Kumar, Raymond Sawaya, Frederick F. Lang, David Piwnica‐Worms, Rivka R. Colen	80
12	miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis 2016 ·Cancer Research ·Jianfei Xue, Aidong Zhou, Yamei Wu, (unknown), Kangyu Lin, Samirkumar B. Amin, Roeland Verhaak, Gregory N. Fuller, Keping Xie, Amy B. Heimberger, Suyun Huang	76
13	PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma 2016 ·Cancer Research ·Sameer Agnihotri, Brian Golbourn, Xi Huang, Marc Remke, Susan Younger, Rob A. Cairns, Alan Chalil, Christian A. Smith, (unknown), (unknown), Patricia Rakopoulos, Vijay Ramaswamy, Michael S. Taccone, Paul S. Mischel, Gregory N. Fuller, Cynthia Hawkins, William L. Stanford, Michael D. Taylor, Gelareh Zadeh, James T. Rutka	109
14	miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma 2013 ·Cancer Research ·Jun Wei, Fei Wang, Ling-Yuan Kong, Shuo Xu, Tiffany Doucette, Sherise D. Ferguson, Yuhui Yang, Kayla McEnery, Krishan R. Jethwa, Olsi Gjyshi, Wei Qiao, Nicholas B. Levine, Frederick F. Lang, Ganesh Rao, Gregory N. Fuller, George A. Călin, Amy B. Heimberger	209
15	Neutrophils Promote the Malignant Glioma Phenotype through S100A4 2013 ·Clinical Cancer Research ·Ji Liang, Yuji Piao, Lindsay Holmes, Gregory N. Fuller, Verlene Henry, Ningyi Tiao, John F. de Groot	235
16	A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas 2011 ·The Journal of Experimental Medicine ·Sameer Agnihotri, Amparo Wolf, Diana M. Muñoz, Chris Smith, Aaron S. Gajadhar, Andrés Ramírez, Ian D. Clarke, Gregory N. Fuller, Santosh Kesari, Peter B. Dirks, C. Jane McGlade, William L. Stanford, Kenneth Aldape, Paul S. Mischel, Cynthia Hawkins, Abhijit Guha	65
17	Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF^β‐TRCP in neuroblastoma cells 2011 ·Cancer ·A. L. Singh, (unknown), Monica Gireud, Stephen A. Fletcher, James E. Baumgartner, Gregory N. Fuller, John Stewart, Peter E. Zage, Vidya Gopalakrishnan	47
18	Transgenic E2F1 Expression in the Mouse Brain Induces a Human-Like Bimodal Pattern of Tumors 2007 ·Cancer Research ·(unknown), D. Gale Johnson, Hong Jiang, Jing Xu, Marta M. Alonso, Kenneth Aldape, Gregory N. Fuller, B. Nebiyou Bekele, W.K. Alfred Yung, Candelaria Gomez‐Manzano, Juàn Fueyo	19
19	Inactivation of the Invasion Inhibitory Gene IIp45 by Alternative Splicing in Gliomas 2005 ·Cancer Research ·Sonya Wei Song, Gregory N. Fuller, Hong Zheng, Wei Zhang	23
20	Identification of combination gene sets for glioma classification. 2002 ·PubMed ·Seungchan Kim, Edward R. Dougherty, Ilya Shmulevich, Kenneth R. Hess, Stanley R. Hamilton, Jeffrey M. Trent, Gregory N. Fuller, Wei Zhang	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact